CJC-1295 with DAC and MOTS-c Interaction

Synergistic
Mechanism-based 51% confidence

CJC-1295 with DAC and MOTS-c have a synergistic interaction with 51% confidence. CJC-1295 with DAC helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

MOTS-c

Mitochondrial-Derived Peptide | Metabolic Regulator

Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.

Half-life: ~30 minutes Typical dose: Start 5mg daily, increase to 10-15mg based on goals longevity, metabolic
ampknrf2 insulin disruptinginsulin sensitizingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, MOTS-c). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 with DAC with MOTS-c?

Yes, CJC-1295 with DAC and MOTS-c can generally be taken together. CJC-1295 with DAC helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is CJC-1295 with DAC and MOTS-c safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and MOTS-c?

CJC-1295 with DAC helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and MOTS-c?

CJC-1295 with DAC has a half-life of 6-8 days and MOTS-c has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs MOTS-c

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.